Biochemical and structural insights of the early glycosylation steps in calicheamicin biosynthesis.

Chemistry & Biology
Changsheng ZhangJon S Thorson

Abstract

The enediyne antibiotic calicheamicin (CLM) gamma(1)(I) is a prominent antitumor agent that is targeted to DNA by a novel aryltetrasaccharide comprised of an aromatic unit and four unusual carbohydrates. Herein we report the heterologous expression and the biochemical characterization of the two "internal" glycosyltransferases CalG3 and CalG2 and the structural elucidation of an enediyne glycosyltransferase (CalG3). In conjunction with the previous characterization of the "external" CLM GTs CalG1 and CalG4, this study completes the functional assignment of all four CLM GTs, extends the utility of enediyne GT-catalyzed reaction reversibility, and presents conclusive evidence of a sequential glycosylation pathway in CLM biosynthesis. This work also reveals the common GT-B structural fold can now be extended to include enediyne GTs.

References

Dec 14, 1990·Science·D L ScottP B Sigler
Nov 1, 1995·Proteins·T MadejS H Bryant
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Oct 6, 1999·Current Opinion in Structural Biology·I Usón, G M Sheldrick
Oct 24, 2001·Current Opinion in Oncology·E L Sievers, M Linenberger
Aug 17, 2002·Science·Wen LiuBen Shen
Aug 17, 2002·Science·Joachim AhlertJon S Thorson
Oct 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·William A BartonDimitar B Nikolov
Oct 24, 2002·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsThomas C Terwilliger
Oct 31, 2002·Chembiochem : a European Journal of Chemical Biology·Tsion BililignJon S Thorson
Jan 22, 2003·Nature Biotechnology·Emmanuel ZazopoulosChris M Farnet
Jul 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Anne M MulichakR Michael Garavito
Sep 13, 2003·Science·John B BigginsJon S Thorson
Jul 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erwin R BoghaertNitin K Damle
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Feb 11, 2005·Chemical Reviews·Ute GalmBen Shen
Jun 28, 2005·Nucleic Acids Research·Lukasz JaroszewskiAdam Godzik
Mar 23, 2006·Acta Crystallographica. Section D, Biological Crystallography·Jay Painter, Ethan A Merritt
Dec 16, 2006·ACS Chemical Biology·Shanteri SinghJon S Thorson
Dec 16, 2006·ACS Chemical Biology·Charles E MelançonHung-wen Liu
Jan 31, 2007·Chembiochem : a European Journal of Chemical Biology·Changsheng ZhangJon S Thorson
Mar 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·David N BolamHarry J Gilbert
Apr 7, 2007·Trends in Microbiology·José A Salas, Carmen Méndez
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Jan 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jian ZhangBen Shen
Apr 10, 2008·Current Topics in Medicinal Chemistry·Steven G Van Lanen, Ben Shen

❮ Previous
Next ❯

Citations

Mar 18, 2009·Applied Microbiology and Biotechnology·Dinesh SimkhadaJae Kyung Sohng
Jan 31, 2012·Biochemistry·Eta A IsiorhoAdrian T Keatinge-Clay
Dec 6, 2008·Journal of the American Chemical Society·Heather D Johnson, Jon S Thorson
Oct 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Aram ChangGeorge N Phillips
Apr 27, 2010·Applied and Environmental Microbiology·Leonard KaysserBertolt Gust
Jun 30, 2009·Phytochemistry·Annette ErbAndreas Bechthold
Aug 6, 2008·Current Opinion in Chemical Biology·Gavin J WilliamsJon S Thorson
Nov 8, 2011·Journal of Molecular Biology·Martin C MoncrieffePeter F Leadlay
Mar 6, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Dong DongBaojian Wu
Jan 28, 2009·Chemistry & Biology·Christine KrauthAndreas Bechthold
Feb 5, 2010·Current Opinion in Chemical Biology·Rajarshi Roychoudhury, Nicola L B Pohl
Jan 10, 2017·Chembiochem : a European Journal of Chemical Biology·Ryan R HughesJon S Thorson
Sep 4, 2015·Chemical Society Reviews·Dong-Mei LiangJian-Jun Qiao
Apr 10, 2014·Chemical Communications : Chem Comm·Alexander GutmannBernd Nidetzky
Mar 5, 2015·Chemical Society Reviews·Sherif I ElshahawiJon S Thorson
Aug 21, 2015·Chembiochem : a European Journal of Chemical Biology·Pauline Peltier-PainJon S Thorson
Sep 18, 2008·Chembiochem : a European Journal of Chemical Biology·Changsheng ZhangJon S Thorson
Mar 26, 2010·Natural Product Reports·Zhao-Xun Liang
Sep 9, 2011·Natural Product Reports·Richard W GanttJon S Thorson
Jun 11, 2014·Acta Crystallographica. Section D, Biological Crystallography·Xiao-Wei ZouTsung-Lin Li
Oct 18, 2019·Chembiochem : a European Journal of Chemical Biology·Ryan R HughesJon S Thorson
Apr 27, 2011·ChemMedChem·Randal D GoffJon S Thorson
Feb 19, 2021·The Biochemical Journal·Ben A WagstaffHelge C Dorfmueller
Apr 5, 2017·Chemical Reviews·Abraham J WaldmanEmily P Balskus
Aug 8, 2013·Journal of the American Chemical Society·Ruidong ChenChangsheng Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.